<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(3)</volume><submitter>Satwik R</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Vaccination against Coronavirus-19 disease (COVID-19) was widely administered from 2021 onwards. There is little information on how this vaccine affected fertility after assisted-reproductive-technology (ART). The aim of this study therefore was to determine if COVID-19 vaccination or time-since-vaccination influenced ART outcomes.&lt;h4>Materials and methods&lt;/h4>In this prospective cohort study, 502 oocyte-retrieval-cycles and 582 subsequent embryo- transfer-cycles were grouped based on COVID-19 vaccine status of the female partner into those with no-exposure, 1-dose and ≥2-dose exposure. Within the exposed cohort, time-since-last-vaccination to embryotransfer- cycle (T&lt;sub>tr&lt;/sub>) was calculated in days. Main outcomes were mean-total-utilizable-embryos, mean-oocyteutili</pubmed_abstract><journal>International journal of fertility &amp; sterility</journal><pagination>207-214</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11245583</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Fertility outcomes in women undergoing Assisted Reproductive Treatments after COVID-19 vaccination: A prospective cohort study.</pubmed_title><pmcid>PMC11245583</pmcid><pubmed_authors>Majumdar A</pubmed_authors><pubmed_authors>Mittal S</pubmed_authors><pubmed_authors>Majumdar G</pubmed_authors><pubmed_authors>Tiwari N</pubmed_authors><pubmed_authors>Satwik R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fertility outcomes in women undergoing Assisted Reproductive Treatments after COVID-19 vaccination: A prospective cohort study.</name><description>&lt;h4>Background&lt;/h4>Vaccination against Coronavirus-19 disease (COVID-19) was widely administered from 2021 onwards. There is little information on how this vaccine affected fertility after assisted-reproductive-technology (ART). The aim of this study therefore was to determine if COVID-19 vaccination or time-since-vaccination influenced ART outcomes.&lt;h4>Materials and methods&lt;/h4>In this prospective cohort study, 502 oocyte-retrieval-cycles and 582 subsequent embryo- transfer-cycles were grouped based on COVID-19 vaccine status of the female partner into those with no-exposure, 1-dose and ≥2-dose exposure. Within the exposed cohort, time-since-last-vaccination to embryotransfer- cycle (T&lt;sub>tr&lt;/sub>) was calculated in days. Main outcomes were mean-total-utilizable-embryos, mean-oocyteutili</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-27T00:57:37.237Z</modification><creation>2025-04-06T18:02:46.053Z</creation></dates><accession>S-EPMC11245583</accession><cross_references><pubmed>38973272</pubmed><doi>10.22074/ijfs.2023.1990869.1444</doi></cross_references></HashMap>